Lobbying Filing Details

Total Spending

$670,000

Activities

5

Lobbyists

3

Gov't Entities

20

Filing Information
Filing UUID:
dbe31484-2f3e-4de1-a93a-3abe724f28fc
Type:
Q2 - 2nd Quarter - Report
Period:
2020 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2020 at 8:09 PM
Income:
$0
Expenses:
$670,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Daniel Bachner
Registrant
ABBVIE, INC.

Biopharmaceutical company

Washington, District of Columbia
Client
ABBVIE INC.
District of Columbia, United States of America
Lobbying Activities (5)
Activity 1
Copyright/Patent/Trademark

Patent litigation reform issues and issues related to post-grant proceedings at the PTO
Value of intellectual property

Lobbyists (3)
  • STEPHEN SCANGO
  • DANIEL BACHNER
  • BINTA BEARD
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Council of Economic Advisers (CEA)
  • Health & Human Services, Dept of (HHS)
Activity 2
Health Issues

H.R. 1425, Patient Protection and Affordable Care Enhancement Act - provisions relating to pharmaceutical price controls
H.R.6383, Uterine Fibroid Research and Education Act of 2020
340B drug discount program policy issues
Drug cost and pricing policy issues
Patient affordability issues
Policy proposals relating to clinical trial diversity
Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021; Notice Requirement for Non-Federal Governmental Plans proposed rule

Lobbyists (3)
  • STEPHEN SCANGO
  • DANIEL BACHNER
  • BINTA BEARD
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Council of Economic Advisers (CEA)
  • Health & Human Services, Dept of (HHS)
Activity 3
Medicare/Medicaid

S. 2543, Prescription Drug Pricing Reduction Act of 2019 - Provisions related to Medicare Part D, Medicaid, and drug pricing
S. 2911, Seniors Prescription Drug Relief Act of 2019 - Provisions related to Medicare Part D and Medicaid rebates
Policy Proposals related to Medicare Part D and patient cost-sharing
Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues
Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization
Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in
Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements

Lobbyists (3)
  • STEPHEN SCANGO
  • DANIEL BACHNER
  • BINTA BEARD
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Council of Economic Advisers (CEA)
  • Health & Human Services, Dept of (HHS)
Activity 4
Taxation/Internal Revenue Code

Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation
Draft legislation relating to economic activity in Puerto Rico
International tax issues, including OECD digital taxation work program

Lobbyists (2)
  • STEPHEN SCANGO
  • DANIEL BACHNER
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Council of Economic Advisers (CEA)
  • Health & Human Services, Dept of (HHS)
Activity 5
Trade (domestic/foreign)

USMCA and related policy issues
Policy proposals impacting biopharmaceutical supply chain

Lobbyists (2)
  • STEPHEN SCANGO
  • DANIEL BACHNER
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Council of Economic Advisers (CEA)
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.